Publications – Page 3 – Center for Communicable Disease Dynamics

Test sensitivity is secondary to frequency and turnaround time for COVID-19 screening.

Author(s): Larremore DB, Wilder B, Lester E, Shehata S, Burke JM, Hay JA, Tambe M, Mina MJ, Parker RJournal: Sci AdvPMID: 33219112 November 2020

The COVID-19 pandemic has created a public health crisis. Because SARS-CoV-2 can spread from individuals with pre-symptomatic, symptomatic, and asymptomatic…

Rethinking Covid-19 Test Sensitivity – A Strategy for Containment.

Author(s): Mina MJ, Parker R, Larremore DBJournal: N Engl J MedPMID: 32997903 September 2020

It’s time to change how we think about the sensitivity of testing for Covid-19. The Food and Drug Administration (FDA)…

Immune life history, vaccination, and the dynamics of SARS-CoV-2 over the next 5 years.

Author(s): Saad-Roy CM, Wagner CE, Baker RE, Morris SE, Farrar J, Graham AL, Levin SA, Mina MJ, Metcalf CJE, Grenfell BTJournal: SciencePMID: 32958581 September 2020

The future trajectory of the Covid-19 pandemic hinges on the dynamics of adaptive immunity against SARS-CoV2; however, salient features of…

Analyzing Conflicting Results in Rapid Point-of-Care COVID-19 Testing

Author(s): Mina MJ, Comer S, Miller S, Quigley M, McKinnon JE, Prentiss TJournal: DASH August 2020

Rapid point-of-care (POC) testing for the SARS-CoV-2 virus provides an ability to quickly test individuals, facilitating near real-time action if…

Waning immunity and re-emergence of measles and mumps in the vaccine era.

Author(s): Yang L, Grenfell BT, Mina MJJournal: Curr Opin VirolPMID: 32634672 July 2020

Vaccine-preventable diseases (VPD) including measles and mumps have been re-emerging in countries with sustained high vaccine coverage. For mumps, waning…

A Global lmmunological Observatory to meet a time of pandemics.

Author(s): Mina MJ, Metcalf CJE, McDermott AB, Douek DC, Farrar J, Grenfell BTJournal: ElifePMID: 32510329 June 2020

SARS-CoV-2 presents an unprecedented international challenge, but it will not be the last such threat. Here, we argue that the…

To Interpret the SARS-CoV-2 Test, Consider the Cycle Threshold Value.

Author(s): Tom MR, Mina MJJournal: Clin Infect DisPMID: 32435816 May 2020

To prevent the spread of COVID-19, it is important to identify and isolate people who are infectious.It is especially important…

Serology for SARS-CoV-2: Apprehensions, opportunities, and the path forward.

Author(s): Bryant JE, Azman AS, Ferrari MJ, Arnold BF, Boni MF, Boum Y, Hayford K, Luquero FJ, Mina MJ, Rodríguez-Barraquer I, Wu JT, Wade D, Vernet G, Leung DTJournal: Sci ImmunolPMID: 32430309 May 2020

Serological testing for SARS-CoV-2 has enormous potential to contribute to COVID-19 pandemic response efforts. However, the required performance characteristics of…

Antibody testing will enhance the power and accuracy of COVID-19-prevention trials.

Author(s): Lipsitch M, Kahn R, Mina MJJournal: Nat MedPMID: 32341581 April 2020

Researchers starting clinical trials of prevention measures for COVID-19 have a unique window of opportunity for collecting blood from the…

Comprehensive Profiling of Zika Virus Risk with Natural and Artificial Mitigating Strategies, United States.

Author(s): Mina MJ, Guterman LB, Allen KE, Omer SBJournal: Emerg Infect DisPMID: 32043959 April 2020

Zika virus is transitioning to become a long-term public health challenge, and countries should remain informed of the risk for…